vs

Side-by-side financial comparison of DigitalBridge Group, Inc. (DBRG) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

DigitalBridge Group, Inc. is the larger business by last-quarter revenue ($105.7M vs $85.1M, roughly 1.2× 4D Molecular Therapeutics, Inc.). DigitalBridge Group, Inc. runs the higher net margin — 61.5% vs 22.8%, a 38.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 4.1%). DigitalBridge Group, Inc. produced more free cash flow last quarter ($258.0M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 19.2%).

DigitalBridge Group, Inc. is a global digital infrastructure investment firm. The company owns, invests in and operates businesses such as cell towers, data centers, fiber, small cells, and edge infrastructure. Headquartered in Boca Raton, DigitalBridge has offices in Los Angeles, New York, Denver, London, and Singapore. As of June 2025, DigitalBridge had US$106 billion of assets under management.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

DBRG vs FDMT — Head-to-Head

Bigger by revenue
DBRG
DBRG
1.2× larger
DBRG
$105.7M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508895.9% gap
FDMT
8508900.0%
4.1%
DBRG
Higher net margin
DBRG
DBRG
38.7% more per $
DBRG
61.5%
22.8%
FDMT
More free cash flow
DBRG
DBRG
$229.5M more FCF
DBRG
$258.0M
$28.5M
FDMT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
19.2%
DBRG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DBRG
DBRG
FDMT
FDMT
Revenue
$105.7M
$85.1M
Net Profit
$65.1M
$19.4M
Gross Margin
Operating Margin
17.3%
Net Margin
61.5%
22.8%
Revenue YoY
4.1%
8508900.0%
Net Profit YoY
139.1%
EPS (diluted)
$0.28
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBRG
DBRG
FDMT
FDMT
Q4 25
$105.7M
$85.1M
Q3 25
$93.3M
$90.0K
Q2 25
$85.3M
$15.0K
Q1 25
$90.1M
$14.0K
Q4 24
$101.6M
$1.0K
Q3 24
$76.6M
$3.0K
Q2 24
$390.3M
$5.0K
Q1 24
$74.4M
$28.0K
Net Profit
DBRG
DBRG
FDMT
FDMT
Q4 25
$65.1M
$19.4M
Q3 25
$31.4M
$-56.9M
Q2 25
$31.6M
$-54.7M
Q1 25
$13.8M
$-48.0M
Q4 24
Q3 24
$13.8M
$-43.8M
Q2 24
$91.4M
$-35.0M
Q1 24
$-29.6M
$-32.4M
Operating Margin
DBRG
DBRG
FDMT
FDMT
Q4 25
17.3%
Q3 25
-13.9%
-67983.3%
Q2 25
-31.2%
-396373.3%
Q1 25
-11.5%
-383007.1%
Q4 24
5.7%
Q3 24
62.4%
-1704400.0%
Q2 24
33.5%
-849120.0%
Q1 24
-20.7%
-136200.0%
Net Margin
DBRG
DBRG
FDMT
FDMT
Q4 25
61.5%
22.8%
Q3 25
33.7%
-63195.6%
Q2 25
37.1%
-364386.7%
Q1 25
15.3%
-342657.1%
Q4 24
Q3 24
18.0%
-1461433.3%
Q2 24
23.4%
-699060.0%
Q1 24
-39.8%
-115717.9%
EPS (diluted)
DBRG
DBRG
FDMT
FDMT
Q4 25
$0.28
$0.43
Q3 25
$0.09
$-1.01
Q2 25
$0.10
$-0.98
Q1 25
$-0.01
$-0.86
Q4 24
Q3 24
$-0.01
$-0.79
Q2 24
$0.44
$-0.63
Q1 24
$-0.28
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBRG
DBRG
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$382.5M
$402.7M
Total DebtLower is stronger
$298.8M
Stockholders' EquityBook value
$2.1B
$505.7M
Total Assets
$3.4B
$566.7M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBRG
DBRG
FDMT
FDMT
Q4 25
$382.5M
$402.7M
Q3 25
$358.4M
$305.1M
Q2 25
$340.7M
$293.2M
Q1 25
$349.9M
$321.4M
Q4 24
$302.2M
$424.9M
Q3 24
$294.4M
$501.9M
Q2 24
$261.2M
$541.9M
Q1 24
$247.4M
$525.9M
Total Debt
DBRG
DBRG
FDMT
FDMT
Q4 25
$298.8M
Q3 25
$327.9M
Q2 25
$298.0M
Q1 25
$296.9M
Q4 24
$296.4M
Q3 24
$295.8M
Q2 24
$295.3M
Q1 24
$366.5M
Stockholders' Equity
DBRG
DBRG
FDMT
FDMT
Q4 25
$2.1B
$505.7M
Q3 25
$2.1B
$369.0M
Q2 25
$2.0B
$420.9M
Q1 25
$2.0B
$469.7M
Q4 24
$2.0B
$510.6M
Q3 24
$2.0B
$552.9M
Q2 24
$2.0B
$588.3M
Q1 24
$1.8B
$600.6M
Total Assets
DBRG
DBRG
FDMT
FDMT
Q4 25
$3.4B
$566.7M
Q3 25
$3.5B
$424.0M
Q2 25
$3.4B
$473.6M
Q1 25
$3.4B
$515.7M
Q4 24
$3.5B
$560.4M
Q3 24
$3.5B
$604.0M
Q2 24
$3.5B
$620.1M
Q1 24
$3.5B
$629.9M
Debt / Equity
DBRG
DBRG
FDMT
FDMT
Q4 25
0.14×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBRG
DBRG
FDMT
FDMT
Operating Cash FlowLast quarter
$259.3M
$28.6M
Free Cash FlowOCF − Capex
$258.0M
$28.5M
FCF MarginFCF / Revenue
244.0%
33.5%
Capex IntensityCapex / Revenue
1.3%
0.1%
Cash ConversionOCF / Net Profit
3.99×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$440.5M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBRG
DBRG
FDMT
FDMT
Q4 25
$259.3M
$28.6M
Q3 25
$56.5M
$-46.5M
Q2 25
$77.0M
$-43.4M
Q1 25
$50.3M
$-47.8M
Q4 24
$60.1M
$-134.6M
Q3 24
$35.9M
$-29.4M
Q2 24
$22.5M
$-30.2M
Q1 24
$-27.0M
$-29.1M
Free Cash Flow
DBRG
DBRG
FDMT
FDMT
Q4 25
$258.0M
$28.5M
Q3 25
$56.1M
$-46.6M
Q2 25
$76.4M
$-43.4M
Q1 25
$50.0M
$-48.4M
Q4 24
$56.5M
$-138.4M
Q3 24
$-31.2M
Q2 24
$22.3M
$-30.6M
Q1 24
$-30.1M
$-29.8M
FCF Margin
DBRG
DBRG
FDMT
FDMT
Q4 25
244.0%
33.5%
Q3 25
60.2%
-51765.6%
Q2 25
89.5%
-289620.0%
Q1 25
55.5%
-345635.7%
Q4 24
55.7%
-13837100.0%
Q3 24
-1038966.7%
Q2 24
5.7%
-611840.0%
Q1 24
-40.4%
-106421.4%
Capex Intensity
DBRG
DBRG
FDMT
FDMT
Q4 25
1.3%
0.1%
Q3 25
0.4%
101.1%
Q2 25
0.7%
440.0%
Q1 25
0.3%
4507.1%
Q4 24
3.5%
378600.0%
Q3 24
0.0%
59266.7%
Q2 24
0.1%
6980.0%
Q1 24
4.1%
2535.7%
Cash Conversion
DBRG
DBRG
FDMT
FDMT
Q4 25
3.99×
1.47×
Q3 25
1.80×
Q2 25
2.43×
Q1 25
3.65×
Q4 24
Q3 24
2.61×
Q2 24
0.25×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons